Morgan Stanley’s Curis CRIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$139K Buy
12,712
+12,709
+423,633% +$237K ﹤0.01% 6026
2025
Q4
$56 Sell
3
-39
-93% -$1.05K ﹤0.01% 7810
2025
Q3
$1.4K Hold
42
﹤0.01% 7358
2025
Q2
$1.96K Hold
42
﹤0.01% 7226
2025
Q1
$1.77K Sell
42
-1
-2% -$62 ﹤0.01% 7195
2024
Q4
$2.61K Hold
43
﹤0.01% 7149
2024
Q3
$4.65K Sell
43
-1
-2% -$112 ﹤0.01% 6930
2024
Q2
$6.13K Hold
44
﹤0.01% 6803
2024
Q1
$9.66K Sell
44
-45
-51% -$9.68K ﹤0.01% 6724
2023
Q4
$22.8K Buy
89
+44
+98% +$7.02K ﹤0.01% 6617
2023
Q3
$5.89K Sell
45
-37
-45% -$9.52K ﹤0.01% 6875
2023
Q2
$27.1K Buy
82
+1
+1% +$325 ﹤0.01% 6451
2023
Q1
$19.4K Sell
81
-494
-86% -$130K ﹤0.01% 6641
2022
Q4
$127K Sell
575
-21
-4% -$6.16K ﹤0.01% 5878
2022
Q3
$167K Buy
596
+218
+58% +$87.9K ﹤0.01% 5811
2022
Q2
$149K Sell
378
-5,313
-93% -$2.22M ﹤0.01% 6040
2022
Q1
$5.42M Buy
5,691
+4,901
+620% +$6.26M ﹤0.01% 3605
2021
Q4
$1.5M Sell
790
-154
-16% -$366K ﹤0.01% 4784
2021
Q3
$2.95M Buy
944
+383
+68% +$1.2M ﹤0.01% 4249
2021
Q2
$1.81M Buy
561
+533
+1,904% +$2.41M ﹤0.01% 4706
2021
Q1
$126K Sell
28
-26
-48% -$109K ﹤0.01% 5890
2020
Q4
$178K Hold
54
﹤0.01% 5647
2020
Q3
$25K Sell
54
-1
-2% -$472 ﹤0.01% 5973
2020
Q2
$26K Sell
55
-1
-2% -$369 ﹤0.01% 5932
2020
Q1
$16K Buy
56
+8
+17% +$4.25K ﹤0.01% 5882
2019
Q4
$33K Sell
48
-3
-6% -$2.18K ﹤0.01% 5969
2019
Q3
$46K Buy
51
+2
+4% +$1.69K ﹤0.01% 5749
2019
Q2
$37K Buy
49
+30
+158% +$21K ﹤0.01% 5720
2019
Q1
$15K Sell
19
-81
-81% -$38.8K ﹤0.01% 6092
2018
Q4
$27K Sell
100
-7
-7% -$3.83K ﹤0.01% 5946
2018
Q3
$76K Sell
107
-406
-79% -$265K ﹤0.01% 5768
2018
Q2
$355K Buy
513
+326
+174% +$334K ﹤0.01% 5298
2018
Q1
$244K Sell
187
-53
-22% -$69.4K ﹤0.01% 5386
2017
Q4
$336K Buy
240
+120
+100% +$282K ﹤0.01% 5186
2017
Q3
$358K Buy
120
+8
+7% +$29.6K ﹤0.01% 5065
2017
Q2
$424K Sell
112
-5
-4% -$20.9K ﹤0.01% 4910
2017
Q1
$648K Sell
117
-89
-43% -$495K ﹤0.01% 4679
2016
Q4
$1.27M Buy
206
+151
+275% +$907K ﹤0.01% 4287
2016
Q3
$290K Sell
55
-9
-14% -$33K ﹤0.01% 4822
2016
Q2
$198K Buy
64
+9
+16% +$32.1K ﹤0.01% 4942
2016
Q1
$176K Sell
55
-11
-17% -$37K ﹤0.01% 5050
2015
Q4
$383K Buy
66
+17
+35% +$83K ﹤0.01% 4714
2015
Q3
$199K Sell
49
-2
-4% -$11.3K ﹤0.01% 5083
2015
Q2
$340K Sell
51
-97
-66% -$583K ﹤0.01% 4956
2015
Q1
$712K Buy
148
+107
+261% +$516K ﹤0.01% 4390
2014
Q4
$122K Sell
41
-12
-23% -$31.5K ﹤0.01% 5469
2014
Q3
$150K Sell
53
-57
-52% -$192K ﹤0.01% 5283
2014
Q2
$408K Buy
110
+64
+139% +$261K ﹤0.01% 4733
2014
Q1
$259K Sell
46
-38
-45% -$228K ﹤0.01% 4973
2013
Q4
$473K Buy
84
+18
+27% +$123K ﹤0.01% 4484
2013
Q3
$587K Buy
66
+24
+57% +$194K ﹤0.01% 4221
2013
Q2
$270K Buy
+42
New +$297K ﹤0.01% 4662

Other funds holding CRIS

Morgan Stanley's CRIS Position: Q1 2026 in Review

Morgan Stanley increased its Curis (CRIS) stake by 423,633% in Q1 2026, buying an estimated $237K and bringing the position to 12,712 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #6026.

Morgan Stanley first reported a position in CRIS in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.42M in Q1 2022. 39 funds tracked by Wall St. Rank hold CRIS as of Q1 2026.

  • Morgan Stanley held 12,712 shares of Curis worth $139K as of Q1 2026.
  • Morgan Stanley bought 12,709 Curis shares in Q1 2026, an estimated $237K.
  • Curis made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6026 holding.
  • Morgan Stanley first reported a position in Curis in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Curis position peaked at $5.42M in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Curis as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.